Navigation Links
Drugs, Doctors and Death: Heath Ledger Becomes Another Victim
Date:2/22/2008

TARPON SPRINGS, Fla., Feb. 22 /PRNewswire/ -- Throughout the past decade, Florida Detox(TM) has successfully treated over 5,000 addicted patients. Interestingly, Florida Detox(TM) has seen an exorbitant increase in the ratio of patients using prescription medications, compared to patients using illicit street drugs. Ten years ago, 50% of our patients were addicted to prescription pain medications. In 2007, 95% of our patients were treated for prescription medication addiction. The recent surge of deaths derived from doctor prescribed medication has far surpassed the overdose prevalence related to illicit street drugs. This alarming trend has recently come to light secondary to the tragic death of Hollywood celebrity Heath Ledger.

This Hollywood actor allegedly overdosed from a combination of physician prescribed opiate pain medication, such as Oxycontin(R), Vicodin(R), or Percocet(R) and a benzodiazepine (Xanax(R), Klonopin(R), Valium(R)) class of anti-anxiety medication. The combination of these two classes of medication can produce a synergistic effect causing respiratory depression and overdose death.

Ironically, the majority of adult patients treated for addiction at Florida Detox(TM) have been prescribed both classes of drugs by their doctor. Many of these patients state that their "pain doctor" simply asks them what opiate or benzo they want, spending less than five minutes with them, during their visit. These patients become dysfunctional at work and home secondary to decreased cognitive ability. Many experience short-term memory problems and frequently forget how much medication they have taken. This phenomenon can precipitate accidental overdose, as in the case of Heath Ledger. Unfortunately, many physicians fail to closely monitor the patient's declining mental function.

Our clinical research demonstrates that patients who "feel more normal" on the combination of these sedating medications typically suffer from an underlying anxiety disorder. These anxiety disorders are usually biochemical in nature and can be effectively treated with non-addictive medication, if properly diagnosed.

Men like Heath Ledger, who suffer anxiety and insomnia disorders, frequently have genetic deficiencies of serotonin or excess production of dopamine, glutamate, phenylethylamine or histamine. The increased prevalence of depression, anxiety, and insomnia disorders in America is multi-factorial and correlates directly to the exponential growth of pill popping patients. Both patients and physicians are responsible for creating America's addiction epidemic.


'/>"/>
SOURCE Florida Detox
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MicroRNAs may be key to HIVs ability to hide, evade drugs, Jefferson scientists find
2. Targeting gut bugs could revolutionize future drugs, say researcher
3. HIV drugs, Abacavir and Didanosine increase the risk of heart attack
4. New understanding of how big molecules bind will lead to better drugs, synthetic organic materials
5. UK junior doctors gaining less experience of common procedures
6. Doctors Often Miss High Blood Pressure in Kids
7. One-fourth of HIV patients believe their doctors stigmatize them
8. Annual flu shot cuts need for doctors visits, hospitalization among children
9. Teens need to see their doctors more often
10. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
11. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... ... Harbour , a DAO (decentralized autonomous organization) that harnesses the wisdom of ... technical specifications . , 2017 has seen an explosion of token launches by blockchain ... will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, said, “We ...
(Date:6/27/2017)... ... June 27, 2017 , ... From June 20-22, EarQ and Widex ... Syracuse, New York, where EarQ is headquartered. , Together, the organizations educate hearing ... today’s savvy consumer, and the latest in hearing technology. At the event, EarQ ...
(Date:6/27/2017)... ... June 27, 2017 , ... PR ... an upcoming case studies guidebook. This guidebook offers an excellent branding and exposure ... include articles, case studies and how-to’s that fall into the following categories:, ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... Hammer Strength, ... Association (NBSCA) have named Javair Gillett of the Houston Rockets the NBSCA Strength & ... the award is decided by NBSCA members who vote to select the coach who ...
(Date:6/27/2017)... ... June 27, 2017 , ... Children’s National Health System ... rankings, with its Neonatology program ranking #1 out of more than 1500 neonatal ... to the coveted Honor Roll, a distinction given to the top performing children’s hospitals ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... 2017  Researchers from DRUGSCAN ® and INC ... a live, complimentary webinar titled, "Untangling methods to tamper ... real world" on Wednesday June 28, 2017 from 12:00 ... webinar will feature interviews with recreational and dependent prescription ... techniques abusers use to prepare opioid tablets for routes ...
(Date:6/14/2017)... , June 14, 2017 The Bio ... City of Fremont and the ... the bio-pharma industry in California ... enabling executive networking, and fostering workforce development. The primary ... and growth of start-ups, as well as small and ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
Breaking Medicine Technology: